Alembic Pharmaceuticals Ltd.
764.90-15.8 (-2.02%)
23 Oct, 12:00 AM
Stock News
Alembic Pharmaceuticals Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
Business Standard
Alembic Pharma receives USFDA approval for generic ear infection drug
Alembic Pharmaceuticals Ltd received final approval from the US Food and Drug Administration for its generic Ciprofloxacin and Dexamethasone Otic Suspension USP, with an estimated US market size of USD 110 million, taking its cumulative ANDA approvals to 246.
19th Oct '26 10:13 am
Read full article on business-standard.com